Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2020 - 12 - 21 save search
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 7.89%
H: 0.98%
C: -11.24%
fda drug new drug application
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
ANIX | News | $3.12 0.65% 0.64% 33K
|
Health Technology
|
| O: 12.9%
H: 2.22%
C: -12.7%
breast cancer vaccine cancer fda clearance fda trial clearance bioscience
Janssen Initiates Rolling Submission of a Biologics License Application to U.S. FDA for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2020-12-21 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.62%
H: 0.92%
C: 0.66%
fda license therapy car-t submission cel
Legend Biotech Announces Initiation of Rolling Submission of Biologics License Application to U.S. FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2020-12-21 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -2.15%
H: 2.64%
C: -0.7%
fda approval biotech license therapy car-t submission cel
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
Published: 2020-12-21 (Crawled : 13:03) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 7.89%
H: 0.98%
C: -11.24%
fda drug new drug application
EyeGate Addresses Majority of FDA’s Action Items with Submission of Investigational Device Exemption Amendment for Ocular Bandage Gel
Published: 2018-05-22 (Crawled : 12:58) - globenewswire.com
EYEG | $34.655 -0.89% 5.8K
|
Health Technology
| Email alert
Add to watchlist
fda ocular eye submission device
EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
Published: 2018-06-22 (Crawled : 12:58) - globenewswire.com
EYEG | $34.655 -0.89% 5.8K
|
Health Technology
| Email alert
Add to watchlist
fda ocular eye submission
EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
Published: 2018-07-24 (Crawled : 12:58) - globenewswire.com
EYEG | $34.655 -0.89% 5.8K
|
Health Technology
| Email alert
Add to watchlist
fda approval fda approval ocular eye submission
EyeGate Pharmaceuticals Announces Meeting Date with FDA
Published: 2019-01-16 (Crawled : 12:58) - globenewswire.com
EYEG | $34.655 -0.89% 5.8K
|
Health Technology
|
| O: 5.32%
H: 0.33%
C: -16.78%
fda eye
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
Published: 2020-12-21 (Crawled : 00:12) - prnewswire.com
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 2.67%
H: 1.3%
C: -3.25%
fda approval fda approval therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.